Ology Bioservices, DOD offer $14Mn to develop COVID-19 antibody
Category: #health  By Mateen Dalal  Date: 2020-03-24
  • share
  • Twitter
  • Facebook
  • LinkedIn

Ology Bioservices, DOD offer $14Mn to develop COVID-19 antibody

In a bid to expedite the COVID-19 drug development process, Ology Bioservices Inc., a privately held American biopharmaceutical firm, along with the Department of Defense (DOD) decided to award a contract worth $14 million, to manufacture and develop a monoclonal antibody for prevention and treatment of infection caused by COVID-19.

Reportedly, this initiative is backed by the Assistant Secretary of Defense for Health Affairs’ Office with funding pouring in from the Defense Health Agency. As a result of this program, Ology Bioservices would join hands with Nashville’s Vanderbilt University Medical Center (VUMC) to manufacture and develop the monoclonal immunoglobulin.

Apparently, this program focuses on efficiently and rapidly providing the antibody to the Department of Defense. Meanwhile, under VUMC’s proposed terms of impending deal, Vanderbilt Vaccine Center’s (VVC) researchers would be tasked to boost their antibody discovery efforts for the performance facility of the U.S. DARPA’s Pandemic Prevention Platform (P3) network.

Speaking on the move, Peter H. Khoury, Ph.D., Chief Executive Officer and President, Ology Bioservices, said that the company is honored to work alongside Vanderbilt University Medical Center and the Department of Defense to immediately mitigate this pandemic.

In fact, Ology Bioservices operated manufacturing facility and advanced development centers readily stand by to fulfill every need of the American warfighter as well as the nation at large.

Meanwhile, Douglas Bryce, Joint Program Executive Officer, CBRN Defense, commented that the medical countermeasures manufacturing and advanced development facility was created for such global health epidemic scenarios.

This facility allows DOD and interagency collaborators like human and health services, alongside its allies in academia and industry to quickly respond and create the treatments for those warfighters who are currently fighting against COVID-19 for the nation.

As for Matthew Hepburn, M.D., Joint Project Lead of CBRN Defense, Enabling Biotechnologies, said that this contract indicates the prior investment’s realization in the DOD Manufacturing and Advanced Development facility, so as to quickly address pandemics and biological threats.

Source Credit: https://finance.yahoo.com/news/ology-bioservices-vanderbilt-university-medical-182500334.html

 

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Alphabet’s Google to face lawsuit from NLRB for violating labor laws
Alphabet’s Google to face lawsuit from NLRB for violating labor laws
By Mateen Dalal

In a recent turn of events, U.S. government body National Labor Relations Board (NLRB) has reportedly issued a complaint against American multinational technology company, Google LLC for unlawfully monitoring as well as questioning its workers and su...

Britain’s CMA to levy tougher competition rules on Google and Facebook
Britain’s CMA to levy tougher competition rules on Google and Facebook
By Mateen Dalal

Facebook and Google accounted for around 80% of the total 14 billion pounds spent on digital advertising in 2019. MOW has reportedly accused Google of modifying its Chromium developer tools and Chrome browser to get greater control over advertiser...

Amazon, U.S. Government team up to prevent sale of counterfeit goods
Amazon, U.S. Government team up to prevent sale of counterfeit goods
By Mateen Dalal

According to reliable sources, Washington-headquartered American multinational technology company, Amazon.com Inc has reportedly initiated a joint venture with the U.S. government’s counterfeit agency, the IPR Center (National Intellectual Prop...